Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Nasopharyngeal Carcinoma 6 Colorectal Neoplasms 4 Lung Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Nasopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Sarcoma 1 Recurrence 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1 Advanced Pancreatic Cancer 1 Adenoviridae Infections 1 Adenocarcinoma of Lung 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Ipilimumab 3 Gemcitabine 3 Etoposide 3 Docetaxel 3 selinexor 2 ribociclib 2 envafolimab 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × Endostatins × Clear all

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡